Beijing, China

Shen Quan Pan

This inventor holds 1 USPTO granted patent. Top assignee: Foshan University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shen Quan Pan. Retrieved from https://idiyas.com/inventor/shen-quan-pan-huh0tpwd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shen Quan Pan in Real-Time Cell Observation

Introduction

Shen Quan Pan is a notable inventor based in Beijing, China. He has made significant contributions to the field of cell observation through his innovative patent. His work focuses on developing methods and tools that enhance the understanding of how compounds or drugs affect cells in real time.

Latest Patents

Shen Quan Pan holds a patent for a marker, method, and kit designed for observing the effect of a compound or drug on cells in real time. The patent discloses a marker that consists of an amino acid sequence shown in SEQ No. 1 and/or SEQ No. 2. Additionally, it includes sequences that have at least 80% homology with these sequences, allowing for effective observation of cellular responses to various compounds or drugs.

Career Highlights

Shen Quan Pan is affiliated with Foshan University, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in biomedical research and drug development.

Collaborations

Shen Quan Pan has collaborated with notable colleagues, including Qinghua Yang and Xiaoyang Li, to further enhance the impact of his research.

Conclusion

Shen Quan Pan's contributions to real-time cell observation through his innovative patent highlight the importance of advancements in biomedical research. His work not only enhances scientific understanding but also paves the way for future innovations in drug development and cellular studies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…